Association Between Measurable Residual Disease in Patients With Intermediate-Risk Acute Myeloid Leukemia and First Remission, Treatment, and Outcomes
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Association Between Measurable Residual Disease in Patients With Intermediate-Risk Acute Myeloid Leukemia and First Remission, Treatment, and Outcomes
Authors
Keywords
-
Journal
JAMA Network Open
Volume 4, Issue 7, Pages e2115991
Publisher
American Medical Association (AMA)
Online
2021-07-08
DOI
10.1001/jamanetworkopen.2021.15991
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Should persons with acute myeloid leukemia (AML) in 1st histological complete remission who are measurable residual disease (MRD) test positive receive an allotransplant?
- (2020) Adriano Venditti et al. LEUKEMIA
- Sorafenib maintenance in patients with FLT3-ITD acute myeloid leukaemia undergoing allogeneic haematopoietic stem-cell transplantation: an open-label, multicentre, randomised phase 3 trial
- (2020) Li Xuan et al. LANCET ONCOLOGY
- How close are we to incorporating measurable residual disease into clinical practice for acute myeloid leukemia?
- (2019) Nicholas J. Short et al. HAEMATOLOGICA
- Acute Myeloid Leukemia, Version 3.2019, NCCN Clinical Practice Guidelines in Oncology
- (2019) Martin S. Tallman et al. Journal of the National Comprehensive Cancer Network
- GIMEMA AML1310 trial of risk-adapted, MRD-directed therapy for young adults with newly diagnosed acute myeloid leukemia
- (2019) Adriano Venditti et al. BLOOD
- Using minimal (measurable) residual disease assessments to guide decision-making for timing of allogeneic transplantation in acute myeloid leukemia
- (2019) Omotayo Fasan CURRENT OPINION IN HEMATOLOGY
- Impact of Conditioning Intensity of Allogeneic Transplantation for Acute Myeloid Leukemia With Genomic Evidence of Residual Disease
- (2019) Christopher S. Hourigan et al. JOURNAL OF CLINICAL ONCOLOGY
- Haploidentical transplantation might have superior graft-versus-leukemia effect than HLA-matched sibling transplantation for high-risk acute myeloid leukemia in first complete remission: a prospective multicentre cohort study
- (2019) Sijian Yu et al. LEUKEMIA
- Comparison of Autologous Stem Cell Transplantation versus Haploidentical Donor Stem Cell Transplantation for Favorable- and Intermediate-Risk Acute Myeloid Leukemia Patients in First Complete Remission
- (2018) Jia Chen et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Outcomes of Intermediate Risk Karyotype Acute Myeloid Leukemia in First Remission Undergoing Autologous Stem Cell Transplantation Compared to Allogeneic Stem Cell Transplantation and Chemotherapy Consolidation: a Retrospective, Propensity-score Adjusted Analysis
- (2018) Wasithep Limvorapitak et al. Clinical Lymphoma Myeloma & Leukemia
- Measurable Residual Disease at Induction Redefines Partial Response in Acute Myeloid Leukemia and Stratifies Outcomes in Patients at Standard Risk Without NPM1 Mutations
- (2018) Sylvie D. Freeman et al. JOURNAL OF CLINICAL ONCOLOGY
- The consensus on indications, conditioning regimen, and donor selection of allogeneic hematopoietic cell transplantation for hematological diseases in China—recommendations from the Chinese Society of Hematology
- (2018) Lanping Xu et al. Journal of Hematology & Oncology
- The consensus on the monitoring, treatment, and prevention of leukemia relapse after allogeneic hematopoietic stem cell transplantation in China
- (2018) Yu Wang et al. CANCER LETTERS
- The role of collateral related donors in haploidentical hematopoietic stem cell transplantation
- (2018) Xiao-Dong Mo et al. Science Bulletin
- Myeloablative haploidentical transplantation is superior to chemotherapy for patients with intermediate-risk acute myelogenous leukemia in first complete remission
- (2018) Meng Lv et al. CLINICAL CANCER RESEARCH
- Measurable residual disease testing in acute myeloid leukaemia
- (2017) C S Hourigan et al. LEUKEMIA
- Combination of cytogenetic classification and MRD status correlates with outcome of autologous versus allogeneic stem cell transplantation in adults with primary acute myeloid leukemia in first remission
- (2017) Jianfeng Yao et al. LEUKEMIA RESEARCH
- Unknown
- (2017) STATISTICS IN MEDICINE
- Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
- (2016) Hartmut Döhner et al. BLOOD
- Comparable outcomes between autologous and allogeneic transplant for adult acute myeloid leukemia in first CR
- (2016) M Mizutani et al. BONE MARROW TRANSPLANTATION
- Autologous stem cell transplantation is still a valid option in good- and intermediate-risk AML: a GITMO survey on 809 patients autografted in first complete remission
- (2016) F Saraceni et al. BONE MARROW TRANSPLANTATION
- Matched and mismatched unrelated donor compared to autologous stem cell transplantation for acute myeloid leukemia in first complete remission: a retrospective, propensity score-weighted analysis from the ALWP of the EBMT
- (2016) Francesco Saraceni et al. Journal of Hematology & Oncology
- Haploidentical Transplantation Without In Vitro T-Cell Depletion Results in Outcomes Equivalent to Those of Contemporaneous Matched Sibling and Unrelated Donor Transplantation for Acute Leukemia
- (2016) Sijian Yu et al. MEDICINE
- Unknown
- (2016) EUROPEAN JOURNAL OF HAEMATOLOGY
- Haploidentical vs identical-sibling transplant for AML in remission: a multicenter, prospective study
- (2015) Yu Wang et al. BLOOD
- Unknown
- (2015) EUROPEAN JOURNAL OF HAEMATOLOGY
- T-cell-replete haploidentical transplantation versus autologous stem cell transplantation in adult acute leukemia: a matched pair analysis
- (2015) N.-C. Gorin et al. HAEMATOLOGICA
- Relation of Clinical Response and Minimal Residual Disease and Their Prognostic Impact on Outcome in Acute Myeloid Leukemia
- (2015) Xueyan Chen et al. JOURNAL OF CLINICAL ONCOLOGY
- T-cell-replete haploidentical transplantation versus autologous stem cell transplantation in adult acute leukemia: a matched pair analysis
- (2015) N.-C. Gorin et al. HAEMATOLOGICA
- T-cell-replete haploidentical HSCT with low-dose anti-T-lymphocyte globulin compared with matched sibling HSCT and unrelated HSCT
- (2014) Y. Luo et al. BLOOD
- Acute Myeloid Leukemia and Myelodysplastic Syndromes in Older Adults
- (2014) Heidi D. Klepin et al. JOURNAL OF CLINICAL ONCOLOGY
- Comparison of minimal residual disease as outcome predictor for AML patients in first complete remission undergoing myeloablative or nonmyeloablative allogeneic hematopoietic cell transplantation
- (2014) R B Walter et al. LEUKEMIA
- Comparative therapeutic value of post-remission approaches in patients with acute myeloid leukemia aged 40–60 years
- (2014) J J Cornelissen et al. LEUKEMIA
- MRD-directed risk stratification treatment may improve outcomes of t(8;21) AML in the first complete remission: results from the AML05 multicenter trial
- (2013) H.-H. Zhu et al. BLOOD
- World Medical Association Declaration of Helsinki
- (2013) JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- T-Cell–Replete HLA-Haploidentical Hematopoietic Transplantation for Hematologic Malignancies Using Post-Transplantation Cyclophosphamide Results in Outcomes Equivalent to Those of Contemporaneous HLA-Matched Related and Unrelated Donor Transplantation
- (2013) Asad Bashey et al. JOURNAL OF CLINICAL ONCOLOGY
- Frequency of Allogeneic Hematopoietic Cell Transplantation Among Patients With High- or Intermediate-Risk Acute Myeloid Leukemia in First Complete Remission
- (2013) Raya Mawad et al. JOURNAL OF CLINICAL ONCOLOGY
- High Prognostic Impact of Flow Cytometric Minimal Residual Disease Detection in Acute Myeloid Leukemia: Data From the HOVON/SAKK AML 42A Study
- (2013) Monique Terwijn et al. JOURNAL OF CLINICAL ONCOLOGY
- Busulfan plus fludarabine as a myeloablative conditioning regimen compared with busulfan plus cyclophosphamide for acute myeloid leukemia in first complete remission undergoing allogeneic hematopoietic stem cell transplantation: a prospective and multicenter study
- (2013) Hui Liu et al. Journal of Hematology & Oncology
- Going Beyond 7 + 3 Regimens in the Treatment of Adult Acute Myeloid Leukemia
- (2012) Ayalew Tefferi et al. JOURNAL OF CLINICAL ONCOLOGY
- Impact of Pretransplantation Minimal Residual Disease, As Detected by Multiparametric Flow Cytometry, on Outcome of Myeloablative Hematopoietic Cell Transplantation for Acute Myeloid Leukemia
- (2011) Roland B. Walter et al. JOURNAL OF CLINICAL ONCOLOGY
- Cytogenetic and molecular diagnostic characterization combined to postconsolidation minimal residual disease assessment by flow cytometry improves risk stratification in adult acute myeloid leukemia
- (2010) F. Buccisano et al. BLOOD
- Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia in First Complete Remission
- (2009) John Koreth et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Age and acute myeloid leukemia: real world data on decision to treat and outcomes from the Swedish Acute Leukemia Registry
- (2008) G. Juliusson et al. BLOOD
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now